

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.60996557 |
| 2 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.36220927 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.29677679 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 6.29677679 |
| 5 | respiratory electron transport chain (GO:0022904) | 5.54220544 |
| 6 | electron transport chain (GO:0022900) | 5.43038459 |
| 7 | protein neddylation (GO:0045116) | 5.02218038 |
| 8 | chaperone-mediated protein transport (GO:0072321) | 4.97783990 |
| 9 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.78577516 |
| 10 | DNA deamination (GO:0045006) | 4.44627677 |
| 11 | fatty acid elongation (GO:0030497) | 4.38304741 |
| 12 | protein complex biogenesis (GO:0070271) | 4.33725663 |
| 13 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.22577342 |
| 14 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.22577342 |
| 15 | NADH dehydrogenase complex assembly (GO:0010257) | 4.22577342 |
| 16 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.15291781 |
| 17 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.01013802 |
| 18 | proteasome assembly (GO:0043248) | 3.94029926 |
| 19 | hydrogen ion transmembrane transport (GO:1902600) | 3.82490910 |
| 20 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.81283960 |
| 21 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.75747091 |
| 22 | axon ensheathment in central nervous system (GO:0032291) | 3.74181763 |
| 23 | central nervous system myelination (GO:0022010) | 3.74181763 |
| 24 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.69271761 |
| 25 | iron-sulfur cluster assembly (GO:0016226) | 3.67492405 |
| 26 | metallo-sulfur cluster assembly (GO:0031163) | 3.67492405 |
| 27 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.62110628 |
| 28 | respiratory chain complex IV assembly (GO:0008535) | 3.56709894 |
| 29 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.54186360 |
| 30 | regulation of female receptivity (GO:0045924) | 3.52677592 |
| 31 | positive regulation of ligase activity (GO:0051351) | 3.50962302 |
| 32 | female mating behavior (GO:0060180) | 3.50696154 |
| 33 | proton transport (GO:0015992) | 3.50113255 |
| 34 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.47815508 |
| 35 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.47815508 |
| 36 | signal peptide processing (GO:0006465) | 3.46952641 |
| 37 | base-excision repair, AP site formation (GO:0006285) | 3.45736284 |
| 38 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.42482657 |
| 39 | hydrogen transport (GO:0006818) | 3.42465010 |
| 40 | ATP biosynthetic process (GO:0006754) | 3.37242144 |
| 41 | cholesterol biosynthetic process (GO:0006695) | 3.29946631 |
| 42 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.28075917 |
| 43 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.26847006 |
| 44 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.25249532 |
| 45 | pseudouridine synthesis (GO:0001522) | 3.24697811 |
| 46 | platelet dense granule organization (GO:0060155) | 3.22794382 |
| 47 | regulation of oxidative phosphorylation (GO:0002082) | 3.21128308 |
| 48 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.20371532 |
| 49 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.18047984 |
| 50 | positive regulation of cell cycle arrest (GO:0071158) | 3.15818747 |
| 51 | dopamine transport (GO:0015872) | 3.12884038 |
| 52 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.12716727 |
| 53 | aldehyde catabolic process (GO:0046185) | 3.11074002 |
| 54 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.09742272 |
| 55 | cytochrome complex assembly (GO:0017004) | 3.07464262 |
| 56 | GDP-mannose metabolic process (GO:0019673) | 3.06983100 |
| 57 | regulation of cellular amine metabolic process (GO:0033238) | 3.05289852 |
| 58 | transferrin transport (GO:0033572) | 3.03787806 |
| 59 | regulation of transcription from RNA polymerase I promoter (GO:0006356) | 3.03406133 |
| 60 | regulation of ligase activity (GO:0051340) | 3.02708105 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.02062729 |
| 62 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.97516299 |
| 63 | protein targeting to mitochondrion (GO:0006626) | 2.97219466 |
| 64 | GTP biosynthetic process (GO:0006183) | 2.95994120 |
| 65 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.95489190 |
| 66 | termination of RNA polymerase III transcription (GO:0006386) | 2.95489190 |
| 67 | substantia nigra development (GO:0021762) | 2.95434636 |
| 68 | dopamine biosynthetic process (GO:0042416) | 2.93729772 |
| 69 | deoxyribonucleotide catabolic process (GO:0009264) | 2.93192173 |
| 70 | sterol biosynthetic process (GO:0016126) | 2.92998404 |
| 71 | cullin deneddylation (GO:0010388) | 2.90583931 |
| 72 | GPI anchor metabolic process (GO:0006505) | 2.90382378 |
| 73 | negative regulation of protein ubiquitination (GO:0031397) | 2.89911716 |
| 74 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.88987491 |
| 75 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.88987491 |
| 76 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.88850232 |
| 77 | regulation of catecholamine metabolic process (GO:0042069) | 2.88152252 |
| 78 | regulation of dopamine metabolic process (GO:0042053) | 2.88152252 |
| 79 | establishment of protein localization to mitochondrion (GO:0072655) | 2.87948409 |
| 80 | anterograde synaptic vesicle transport (GO:0048490) | 2.86346702 |
| 81 | oxidative phosphorylation (GO:0006119) | 2.86023982 |
| 82 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.83320423 |
| 83 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.82069988 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.80605485 |
| 85 | rRNA modification (GO:0000154) | 2.80283608 |
| 86 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.80274186 |
| 87 | deoxyribose phosphate catabolic process (GO:0046386) | 2.79579137 |
| 88 | ferric iron transport (GO:0015682) | 2.79273019 |
| 89 | trivalent inorganic cation transport (GO:0072512) | 2.79273019 |
| 90 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.78781639 |
| 91 | L-phenylalanine metabolic process (GO:0006558) | 2.78781639 |
| 92 | regulation of cell cycle arrest (GO:0071156) | 2.78298116 |
| 93 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.77872426 |
| 94 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.77553770 |
| 95 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.76581930 |
| 96 | positive regulation of mitochondrial fission (GO:0090141) | 2.74843103 |
| 97 | keratinocyte development (GO:0003334) | 2.73163426 |
| 98 | lactate metabolic process (GO:0006089) | 2.71477466 |
| 99 | protein maturation by protein folding (GO:0022417) | 2.71005230 |
| 100 | isoprenoid biosynthetic process (GO:0008299) | 2.70393812 |
| 101 | protein localization to mitochondrion (GO:0070585) | 2.69648500 |
| 102 | protein deneddylation (GO:0000338) | 2.68088611 |
| 103 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.67779414 |
| 104 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.67779414 |
| 105 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.67779414 |
| 106 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.67730326 |
| 107 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.67730326 |
| 108 | intracellular protein transmembrane import (GO:0044743) | 2.67598201 |
| 109 | regulation of mitochondrial translation (GO:0070129) | 2.65493081 |
| 110 | GPI anchor biosynthetic process (GO:0006506) | 2.64799401 |
| 111 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.63305222 |
| 112 | nucleotide transmembrane transport (GO:1901679) | 2.62199806 |
| 113 | phagosome maturation (GO:0090382) | 2.59851920 |
| 114 | peptidyl-histidine modification (GO:0018202) | 2.58994326 |
| 115 | mannosylation (GO:0097502) | 2.57942844 |
| 116 | L-methionine salvage (GO:0071267) | 2.57217557 |
| 117 | L-methionine biosynthetic process (GO:0071265) | 2.57217557 |
| 118 | amino acid salvage (GO:0043102) | 2.57217557 |
| 119 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.56862161 |
| 120 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.55452699 |
| 121 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.55452699 |
| 122 | mitochondrial transport (GO:0006839) | 2.55319905 |
| 123 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.54907397 |
| 124 | negative regulation of ligase activity (GO:0051352) | 2.54907397 |
| 125 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.54666319 |
| 126 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.53591617 |
| 127 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.52985946 |
| 128 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.52487298 |
| 129 | L-phenylalanine catabolic process (GO:0006559) | 2.52487298 |
| 130 | glutathione biosynthetic process (GO:0006750) | 2.49966598 |
| 131 | inner mitochondrial membrane organization (GO:0007007) | 2.49407874 |
| 132 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.49168576 |
| 133 | ER overload response (GO:0006983) | 2.46956724 |
| 134 | 7-methylguanosine mRNA capping (GO:0006370) | 2.45498272 |
| 135 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.44843079 |
| 136 | protein-cofactor linkage (GO:0018065) | 2.43846313 |
| 137 | amyloid precursor protein metabolic process (GO:0042982) | 2.42649065 |
| 138 | response to redox state (GO:0051775) | 2.41980345 |
| 139 | 7-methylguanosine RNA capping (GO:0009452) | 2.41147511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.96742671 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.65771579 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.65694014 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.52045186 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.46329723 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.19804680 |
| 7 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.04330318 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.92469848 |
| 9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.76792633 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.65103053 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.62463113 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.61499682 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.45126353 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.41031424 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.39200038 |
| 16 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.19328292 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.19005619 |
| 18 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99923524 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.99007365 |
| 20 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.86776652 |
| 21 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81043580 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.79740967 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.78192122 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78067278 |
| 25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.72993356 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.72003195 |
| 27 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69530160 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.67381715 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.66243229 |
| 30 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.66028496 |
| 31 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.63342215 |
| 32 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.58020814 |
| 33 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.57626625 |
| 34 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.57570092 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.52918494 |
| 36 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.52216352 |
| 37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.51190601 |
| 38 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.49551355 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.49464757 |
| 40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45836406 |
| 41 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.42175146 |
| 42 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.41558601 |
| 43 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.38378665 |
| 44 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.37670373 |
| 45 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36282222 |
| 46 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.36135112 |
| 47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33723164 |
| 48 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.32956952 |
| 49 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.31010876 |
| 50 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.29840062 |
| 51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.29435114 |
| 52 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.29418780 |
| 53 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29055132 |
| 54 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.27982121 |
| 55 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22904116 |
| 56 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.22174475 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22164284 |
| 58 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19255579 |
| 59 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.18908573 |
| 60 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.18195069 |
| 61 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.17601684 |
| 62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15167571 |
| 63 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.14853668 |
| 64 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.14690408 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14624153 |
| 66 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.13625332 |
| 67 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12059296 |
| 68 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11576347 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09731095 |
| 70 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.09627733 |
| 71 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.09388218 |
| 72 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.09165049 |
| 73 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08664373 |
| 74 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.08373590 |
| 75 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07390681 |
| 76 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.06229800 |
| 77 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.06003090 |
| 78 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.05613814 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05554520 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03717377 |
| 81 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.03165203 |
| 82 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.02134729 |
| 83 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02025160 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.01970266 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01447133 |
| 86 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.01352130 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01012470 |
| 88 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00523231 |
| 89 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00200864 |
| 90 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.00038722 |
| 91 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.00001622 |
| 92 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.99822836 |
| 93 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.99273120 |
| 94 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99060633 |
| 95 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97758235 |
| 96 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97159190 |
| 97 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.96960667 |
| 98 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96728105 |
| 99 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.95673042 |
| 100 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95615898 |
| 101 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.95202703 |
| 102 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.95174676 |
| 103 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94910558 |
| 104 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.94480194 |
| 105 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93891097 |
| 106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.93198977 |
| 107 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.92456671 |
| 108 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.92367543 |
| 109 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.92069600 |
| 110 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.91963426 |
| 111 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90851246 |
| 112 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90598732 |
| 113 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.90503145 |
| 114 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.90471101 |
| 115 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.90405328 |
| 116 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.90361132 |
| 117 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.90286298 |
| 118 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.89613864 |
| 119 | NCOR_22424771_ChIP-Seq_293T_Human | 0.89537249 |
| 120 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.88741050 |
| 121 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88719843 |
| 122 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.88458026 |
| 123 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.88375350 |
| 124 | ERA_21632823_ChIP-Seq_H3396_Human | 0.87290666 |
| 125 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.87137746 |
| 126 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.87113841 |
| 127 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.87106581 |
| 128 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.87040374 |
| 129 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86221473 |
| 130 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86221473 |
| 131 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.85416747 |
| 132 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.85377671 |
| 133 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.84189479 |
| 134 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84050174 |
| 135 | P68_20966046_ChIP-Seq_HELA_Human | 0.83982172 |
| 136 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.83733665 |
| 137 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83617328 |
| 138 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.83314801 |
| 139 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83229893 |
| 140 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83114990 |
| 141 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.80909606 |
| 142 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80863206 |
| 143 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.79638629 |
| 144 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.79529833 |
| 145 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78392028 |
| 146 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78242031 |
| 147 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.76941048 |
| 148 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.76908256 |
| 149 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.76525769 |
| 150 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.76354144 |
| 151 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.75691405 |
| 152 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.75235484 |
| 153 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.75060097 |
| 154 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74919385 |
| 155 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.74788519 |
| 156 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74684057 |
| 157 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.74576993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.61583648 |
| 2 | MP0001529_abnormal_vocalization | 2.99225437 |
| 3 | MP0001905_abnormal_dopamine_level | 2.92476887 |
| 4 | MP0003195_calcinosis | 2.79968428 |
| 5 | MP0003786_premature_aging | 2.48433132 |
| 6 | MP0006276_abnormal_autonomic_nervous | 2.39953045 |
| 7 | MP0004270_analgesia | 2.36663214 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.28369788 |
| 9 | MP0002653_abnormal_ependyma_morphology | 2.14828584 |
| 10 | MP0002132_abnormal_respiratory_system | 2.11562972 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.07930641 |
| 12 | MP0004043_abnormal_pH_regulation | 2.04126760 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.02412537 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.01262885 |
| 15 | MP0001986_abnormal_taste_sensitivity | 1.99989537 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 1.99281631 |
| 17 | MP0006036_abnormal_mitochondrial_physio | 1.98447191 |
| 18 | MP0000920_abnormal_myelination | 1.98199796 |
| 19 | MP0001984_abnormal_olfaction | 1.96527823 |
| 20 | MP0003186_abnormal_redox_activity | 1.95179139 |
| 21 | MP0002272_abnormal_nervous_system | 1.93016784 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.90409927 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.89644903 |
| 24 | MP0009379_abnormal_foot_pigmentation | 1.86004906 |
| 25 | MP0008058_abnormal_DNA_repair | 1.85432893 |
| 26 | MP0001970_abnormal_pain_threshold | 1.81454616 |
| 27 | MP0002736_abnormal_nociception_after | 1.78973945 |
| 28 | MP0004142_abnormal_muscle_tone | 1.78860191 |
| 29 | MP0002064_seizures | 1.71680277 |
| 30 | MP0008260_abnormal_autophagy | 1.67618729 |
| 31 | MP0002638_abnormal_pupillary_reflex | 1.67234085 |
| 32 | MP0002822_catalepsy | 1.66265647 |
| 33 | MP0003123_paternal_imprinting | 1.65046076 |
| 34 | MP0005379_endocrine/exocrine_gland_phen | 1.64098271 |
| 35 | MP0002733_abnormal_thermal_nociception | 1.63881084 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.60586997 |
| 37 | MP0003136_yellow_coat_color | 1.57542518 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.57485564 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.55914985 |
| 40 | MP0005451_abnormal_body_composition | 1.54910922 |
| 41 | MP0009785_altered_susceptibility_to | 1.54834594 |
| 42 | MP0000372_irregular_coat_pigmentation | 1.54409751 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.54101478 |
| 44 | MP0009745_abnormal_behavioral_response | 1.53855922 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 1.52535973 |
| 46 | MP0003693_abnormal_embryo_hatching | 1.50574096 |
| 47 | MP0003329_amyloid_beta_deposits | 1.49910016 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.46587269 |
| 49 | MP0002139_abnormal_hepatobiliary_system | 1.44411216 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.42307543 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 1.41133272 |
| 52 | MP0002163_abnormal_gland_morphology | 1.40982010 |
| 53 | MP0004147_increased_porphyrin_level | 1.40875400 |
| 54 | MP0003635_abnormal_synaptic_transmissio | 1.39458626 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 1.39219161 |
| 56 | MP0002282_abnormal_trachea_morphology | 1.39129951 |
| 57 | MP0003137_abnormal_impulse_conducting | 1.38649239 |
| 58 | MP0002102_abnormal_ear_morphology | 1.36798899 |
| 59 | MP0000358_abnormal_cell_content/ | 1.36560748 |
| 60 | MP0004742_abnormal_vestibular_system | 1.35304796 |
| 61 | MP0000750_abnormal_muscle_regeneration | 1.33794144 |
| 62 | MP0008932_abnormal_embryonic_tissue | 1.33772231 |
| 63 | MP0005330_cardiomyopathy | 1.30690340 |
| 64 | MP0005646_abnormal_pituitary_gland | 1.30616959 |
| 65 | MP0005332_abnormal_amino_acid | 1.29717025 |
| 66 | MP0005535_abnormal_body_temperature | 1.28974027 |
| 67 | MP0001764_abnormal_homeostasis | 1.27307743 |
| 68 | MP0009046_muscle_twitch | 1.27298907 |
| 69 | MP0002063_abnormal_learning/memory/cond | 1.25514184 |
| 70 | MP0000613_abnormal_salivary_gland | 1.23866725 |
| 71 | MP0002229_neurodegeneration | 1.23383222 |
| 72 | MP0001486_abnormal_startle_reflex | 1.22075410 |
| 73 | MP0005408_hypopigmentation | 1.21907955 |
| 74 | MP0001501_abnormal_sleep_pattern | 1.21167759 |
| 75 | MP0004019_abnormal_vitamin_homeostasis | 1.19731847 |
| 76 | MP0001664_abnormal_digestion | 1.18826535 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 1.18276418 |
| 78 | MP0001919_abnormal_reproductive_system | 1.17221885 |
| 79 | MP0005386_behavior/neurological_phenoty | 1.16841362 |
| 80 | MP0004924_abnormal_behavior | 1.16841362 |
| 81 | MP0003011_delayed_dark_adaptation | 1.16002955 |
| 82 | MP0002751_abnormal_autonomic_nervous | 1.15794708 |
| 83 | MP0002067_abnormal_sensory_capabilities | 1.15015064 |
| 84 | MP0004084_abnormal_cardiac_muscle | 1.14514492 |
| 85 | MP0005645_abnormal_hypothalamus_physiol | 1.12362582 |
| 86 | MP0001270_distended_abdomen | 1.11469089 |
| 87 | MP0005423_abnormal_somatic_nervous | 1.11348811 |
| 88 | MP0001727_abnormal_embryo_implantation | 1.10519362 |
| 89 | MP0005085_abnormal_gallbladder_physiolo | 1.09109634 |
| 90 | MP0002160_abnormal_reproductive_system | 1.08486985 |
| 91 | MP0001873_stomach_inflammation | 1.07236956 |
| 92 | MP0002693_abnormal_pancreas_physiology | 1.07025572 |
| 93 | MP0002184_abnormal_innervation | 1.05388927 |
| 94 | MP0003879_abnormal_hair_cell | 1.05275109 |
| 95 | MP0001881_abnormal_mammary_gland | 1.04873028 |
| 96 | MP0005365_abnormal_bile_salt | 1.04528417 |
| 97 | MP0002909_abnormal_adrenal_gland | 1.04396745 |
| 98 | MP0009697_abnormal_copulation | 1.04157082 |
| 99 | MP0005389_reproductive_system_phenotype | 1.04019077 |
| 100 | MP0000778_abnormal_nervous_system | 1.03565474 |
| 101 | MP0004381_abnormal_hair_follicle | 1.03293829 |
| 102 | MP0005409_darkened_coat_color | 1.03037785 |
| 103 | MP0008995_early_reproductive_senescence | 1.02450112 |
| 104 | MP0000678_abnormal_parathyroid_gland | 1.02426500 |
| 105 | MP0005171_absent_coat_pigmentation | 1.02186364 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02140644 |
| 107 | MP0000013_abnormal_adipose_tissue | 1.00414755 |
| 108 | MP0005367_renal/urinary_system_phenotyp | 1.00123708 |
| 109 | MP0000516_abnormal_urinary_system | 1.00123708 |
| 110 | MP0005083_abnormal_biliary_tract | 0.99872204 |
| 111 | MP0002090_abnormal_vision | 0.98934705 |
| 112 | MP0001542_abnormal_bone_strength | 0.98406818 |
| 113 | MP0009643_abnormal_urine_homeostasis | 0.97322899 |
| 114 | MP0000681_abnormal_thyroid_gland | 0.96381441 |
| 115 | MP0000015_abnormal_ear_pigmentation | 0.95595705 |
| 116 | MP0004859_abnormal_synaptic_plasticity | 0.94537869 |
| 117 | MP0001963_abnormal_hearing_physiology | 0.93711312 |
| 118 | MP0001756_abnormal_urination | 0.92999459 |
| 119 | MP0003634_abnormal_glial_cell | 0.92950020 |
| 120 | MP0001666_abnormal_nutrient_absorption | 0.91628825 |
| 121 | MP0000538_abnormal_urinary_bladder | 0.91330349 |
| 122 | MP0008873_increased_physiological_sensi | 0.90621582 |
| 123 | MP0002066_abnormal_motor_capabilities/c | 0.90329809 |
| 124 | MP0001485_abnormal_pinna_reflex | 0.90313420 |
| 125 | MP0003718_maternal_effect | 0.88928666 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.88715551 |
| 127 | MP0005075_abnormal_melanosome_morpholog | 0.88686336 |
| 128 | MP0009840_abnormal_foam_cell | 0.87165804 |
| 129 | MP0002557_abnormal_social/conspecific_i | 0.86628765 |
| 130 | MP0002148_abnormal_hypersensitivity_rea | 0.86613188 |
| 131 | MP0008007_abnormal_cellular_replicative | 0.86491570 |
| 132 | MP0008789_abnormal_olfactory_epithelium | 0.86266082 |
| 133 | MP0001765_abnormal_ion_homeostasis | 0.86182864 |
| 134 | MP0005084_abnormal_gallbladder_morpholo | 0.86158867 |
| 135 | MP0002938_white_spotting | 0.84960521 |
| 136 | MP0006082_CNS_inflammation | 0.84938852 |
| 137 | MP0000858_altered_metastatic_potential | 0.82190659 |
| 138 | MP0005410_abnormal_fertilization | 0.82166015 |
| 139 | MP0006072_abnormal_retinal_apoptosis | 0.81506097 |
| 140 | MP0001188_hyperpigmentation | 0.80705999 |
| 141 | MP0008872_abnormal_physiological_respon | 0.80680550 |
| 142 | MP0001502_abnormal_circadian_rhythm | 0.79944858 |
| 143 | MP0001944_abnormal_pancreas_morphology | 0.78846632 |
| 144 | MP0005551_abnormal_eye_electrophysiolog | 0.78754522 |
| 145 | MP0005671_abnormal_response_to | 0.77774380 |
| 146 | MP0000955_abnormal_spinal_cord | 0.77366363 |
| 147 | MP0003638_abnormal_response/metabolism_ | 0.76770730 |
| 148 | MP0002882_abnormal_neuron_morphology | 0.76753041 |
| 149 | MP0003724_increased_susceptibility_to | 0.75723192 |
| 150 | MP0000639_abnormal_adrenal_gland | 0.74302536 |
| 151 | MP0000647_abnormal_sebaceous_gland | 0.73141797 |
| 152 | MP0003787_abnormal_imprinting | 0.72679016 |
| 153 | MP0005220_abnormal_exocrine_pancreas | 0.68577318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.75735489 |
| 2 | Mitochondrial inheritance (HP:0001427) | 5.17911979 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.14292200 |
| 4 | Acute encephalopathy (HP:0006846) | 4.91790663 |
| 5 | Progressive macrocephaly (HP:0004481) | 4.72165070 |
| 6 | Hepatocellular necrosis (HP:0001404) | 4.56956679 |
| 7 | Increased CSF lactate (HP:0002490) | 4.38008845 |
| 8 | Hepatic necrosis (HP:0002605) | 4.16865222 |
| 9 | Renal Fanconi syndrome (HP:0001994) | 4.10899979 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.98748768 |
| 11 | Lipid accumulation in hepatocytes (HP:0006561) | 3.64389937 |
| 12 | Cerebral edema (HP:0002181) | 3.51784742 |
| 13 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.51427310 |
| 14 | 3-Methylglutaconic aciduria (HP:0003535) | 3.50102835 |
| 15 | Increased serum pyruvate (HP:0003542) | 3.49043023 |
| 16 | Abnormality of glycolysis (HP:0004366) | 3.49043023 |
| 17 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.48453352 |
| 18 | Parakeratosis (HP:0001036) | 3.42048274 |
| 19 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.36055702 |
| 20 | Leukodystrophy (HP:0002415) | 3.20954038 |
| 21 | Respiratory failure (HP:0002878) | 3.18174503 |
| 22 | Lactic acidosis (HP:0003128) | 3.17136878 |
| 23 | Ependymoma (HP:0002888) | 3.15875993 |
| 24 | Hypothermia (HP:0002045) | 3.12731822 |
| 25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.10349012 |
| 26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.10349012 |
| 27 | Increased intramyocellular lipid droplets (HP:0012240) | 3.03449662 |
| 28 | Abnormality of renal resorption (HP:0011038) | 3.03120760 |
| 29 | Optic disc pallor (HP:0000543) | 3.00275859 |
| 30 | Neuroendocrine neoplasm (HP:0100634) | 2.94289489 |
| 31 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.92017303 |
| 32 | Astrocytoma (HP:0009592) | 2.91198788 |
| 33 | Abnormality of the astrocytes (HP:0100707) | 2.91198788 |
| 34 | Pheochromocytoma (HP:0002666) | 2.87021795 |
| 35 | Exercise intolerance (HP:0003546) | 2.81948817 |
| 36 | Increased serum lactate (HP:0002151) | 2.80839529 |
| 37 | Exertional dyspnea (HP:0002875) | 2.69760464 |
| 38 | Concave nail (HP:0001598) | 2.69273699 |
| 39 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.66273352 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.61198157 |
| 41 | Myokymia (HP:0002411) | 2.59446899 |
| 42 | Abnormality of urine glucose concentration (HP:0011016) | 2.56722191 |
| 43 | Glycosuria (HP:0003076) | 2.56722191 |
| 44 | Hyperphosphaturia (HP:0003109) | 2.50733586 |
| 45 | Microretrognathia (HP:0000308) | 2.49637158 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.44375326 |
| 47 | Cerebral hypomyelination (HP:0006808) | 2.40756340 |
| 48 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.37605965 |
| 49 | Abnormal protein glycosylation (HP:0012346) | 2.37605965 |
| 50 | Abnormal glycosylation (HP:0012345) | 2.37605965 |
| 51 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.37605965 |
| 52 | Neurofibrillary tangles (HP:0002185) | 2.34131091 |
| 53 | Stomach cancer (HP:0012126) | 2.31399033 |
| 54 | CNS demyelination (HP:0007305) | 2.29677072 |
| 55 | X-linked dominant inheritance (HP:0001423) | 2.28719433 |
| 56 | Degeneration of anterior horn cells (HP:0002398) | 2.28572449 |
| 57 | Abnormality of the anterior horn cell (HP:0006802) | 2.28572449 |
| 58 | Lethargy (HP:0001254) | 2.27739663 |
| 59 | Alveolar cell carcinoma (HP:0006519) | 2.25323923 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 2.21552295 |
| 61 | Respiratory difficulties (HP:0002880) | 2.19207986 |
| 62 | Glioma (HP:0009733) | 2.18320033 |
| 63 | Congenital malformation of the right heart (HP:0011723) | 2.15604094 |
| 64 | Double outlet right ventricle (HP:0001719) | 2.15604094 |
| 65 | Sparse eyelashes (HP:0000653) | 2.14910907 |
| 66 | Hyperthyroidism (HP:0000836) | 2.14400517 |
| 67 | Abnormal urine phosphate concentration (HP:0012599) | 2.13714912 |
| 68 | Limb dystonia (HP:0002451) | 2.12689039 |
| 69 | Generalized aminoaciduria (HP:0002909) | 2.12396158 |
| 70 | Methylmalonic aciduria (HP:0012120) | 2.09700563 |
| 71 | Abnormal pupillary function (HP:0007686) | 2.09384973 |
| 72 | Petechiae (HP:0000967) | 2.09081485 |
| 73 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.08899633 |
| 74 | Emotional lability (HP:0000712) | 2.03220751 |
| 75 | Progressive microcephaly (HP:0000253) | 2.02160398 |
| 76 | Spastic paraparesis (HP:0002313) | 2.01247452 |
| 77 | Prolonged neonatal jaundice (HP:0006579) | 1.98953690 |
| 78 | Hypoplasia of the uterus (HP:0000013) | 1.96223391 |
| 79 | Abnormality of magnesium homeostasis (HP:0004921) | 1.92462661 |
| 80 | Sensory axonal neuropathy (HP:0003390) | 1.92300727 |
| 81 | Renal tubular dysfunction (HP:0000124) | 1.89964443 |
| 82 | Cerebral hemorrhage (HP:0001342) | 1.89718569 |
| 83 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.89407817 |
| 84 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.89407817 |
| 85 | Abnormal hair whorl (HP:0010721) | 1.87885988 |
| 86 | Aplastic anemia (HP:0001915) | 1.87618303 |
| 87 | Rough bone trabeculation (HP:0100670) | 1.87578583 |
| 88 | Delusions (HP:0000746) | 1.87029039 |
| 89 | Medial flaring of the eyebrow (HP:0010747) | 1.83659322 |
| 90 | Testicular atrophy (HP:0000029) | 1.83430961 |
| 91 | Tongue fasciculations (HP:0001308) | 1.83412526 |
| 92 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.83159716 |
| 93 | Dysautonomia (HP:0002459) | 1.83025419 |
| 94 | Autoamputation (HP:0001218) | 1.82874297 |
| 95 | Poor suck (HP:0002033) | 1.80915686 |
| 96 | Focal motor seizures (HP:0011153) | 1.79650540 |
| 97 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.79267787 |
| 98 | Abnormality of alanine metabolism (HP:0010916) | 1.79267787 |
| 99 | Hyperalaninemia (HP:0003348) | 1.79267787 |
| 100 | Hyperventilation (HP:0002883) | 1.79232229 |
| 101 | Retinal dysplasia (HP:0007973) | 1.78413791 |
| 102 | Hypomagnesemia (HP:0002917) | 1.77556595 |
| 103 | Abnormality of dental color (HP:0011073) | 1.77447829 |
| 104 | Opisthotonus (HP:0002179) | 1.76693279 |
| 105 | Flat capital femoral epiphysis (HP:0003370) | 1.74437589 |
| 106 | Pancytopenia (HP:0001876) | 1.73474328 |
| 107 | Epiphyseal stippling (HP:0010655) | 1.73445675 |
| 108 | Diminished movement (HP:0002374) | 1.71363504 |
| 109 | Methylmalonic acidemia (HP:0002912) | 1.71173339 |
| 110 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.70546866 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 1.69021774 |
| 112 | Vomiting (HP:0002013) | 1.68105969 |
| 113 | Microvesicular hepatic steatosis (HP:0001414) | 1.67828581 |
| 114 | Brushfield spots (HP:0001088) | 1.67282534 |
| 115 | Conjugated hyperbilirubinemia (HP:0002908) | 1.67281001 |
| 116 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.66834965 |
| 117 | Dicarboxylic aciduria (HP:0003215) | 1.66834965 |
| 118 | Ketosis (HP:0001946) | 1.66425387 |
| 119 | Ketoacidosis (HP:0001993) | 1.66005112 |
| 120 | Abnormal tarsal ossification (HP:0008369) | 1.65835542 |
| 121 | Amniotic constriction ring (HP:0009775) | 1.64561157 |
| 122 | Abnormality of placental membranes (HP:0011409) | 1.64561157 |
| 123 | Gliosis (HP:0002171) | 1.64155382 |
| 124 | Abnormality of midbrain morphology (HP:0002418) | 1.63724410 |
| 125 | Molar tooth sign on MRI (HP:0002419) | 1.63724410 |
| 126 | Blindness (HP:0000618) | 1.63346965 |
| 127 | Gait imbalance (HP:0002141) | 1.62210254 |
| 128 | Poor speech (HP:0002465) | 1.60617011 |
| 129 | CNS hypomyelination (HP:0003429) | 1.58972166 |
| 130 | Type I transferrin isoform profile (HP:0003642) | 1.56815475 |
| 131 | Hypokinesia (HP:0002375) | 1.56777906 |
| 132 | Polyphagia (HP:0002591) | 1.55240047 |
| 133 | Congenital primary aphakia (HP:0007707) | 1.53959420 |
| 134 | Nephrogenic diabetes insipidus (HP:0009806) | 1.53710570 |
| 135 | Split foot (HP:0001839) | 1.51647439 |
| 136 | Vaginal atresia (HP:0000148) | 1.51204961 |
| 137 | Muscular hypotonia of the trunk (HP:0008936) | 1.50895118 |
| 138 | Progressive neurologic deterioration (HP:0002344) | 1.50117156 |
| 139 | Supranuclear gaze palsy (HP:0000605) | 1.48903851 |
| 140 | Poor head control (HP:0002421) | 1.48466751 |
| 141 | Genital tract atresia (HP:0001827) | 1.48215822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.08078708 |
| 2 | MATK | 3.75980574 |
| 3 | ARAF | 3.67059423 |
| 4 | STK16 | 2.88018977 |
| 5 | MAP3K12 | 2.76985537 |
| 6 | STK39 | 2.67505782 |
| 7 | MST4 | 2.55023781 |
| 8 | CASK | 2.53127142 |
| 9 | TLK1 | 2.50261654 |
| 10 | OXSR1 | 2.36847689 |
| 11 | BCR | 2.32623612 |
| 12 | NME1 | 2.32359592 |
| 13 | WNK4 | 2.18727144 |
| 14 | PIM2 | 2.01607783 |
| 15 | NME2 | 1.81270098 |
| 16 | CDK19 | 1.80868136 |
| 17 | LIMK1 | 1.79388901 |
| 18 | STK24 | 1.76490610 |
| 19 | TRIM28 | 1.75169228 |
| 20 | GRK5 | 1.74947096 |
| 21 | MAPKAPK3 | 1.73457039 |
| 22 | PBK | 1.71437848 |
| 23 | KDR | 1.60761688 |
| 24 | MAP4K2 | 1.57259931 |
| 25 | EIF2AK3 | 1.54703050 |
| 26 | MARK1 | 1.54311324 |
| 27 | LMTK2 | 1.53148247 |
| 28 | GRK7 | 1.51231723 |
| 29 | ILK | 1.50873073 |
| 30 | DYRK2 | 1.49806246 |
| 31 | MYLK | 1.49662516 |
| 32 | ZAK | 1.43654920 |
| 33 | ADRBK2 | 1.41072900 |
| 34 | BMPR2 | 1.40936798 |
| 35 | TNIK | 1.36937903 |
| 36 | EIF2AK1 | 1.36311347 |
| 37 | MST1R | 1.35966641 |
| 38 | BRAF | 1.32118977 |
| 39 | WNK3 | 1.29298938 |
| 40 | BCKDK | 1.27269564 |
| 41 | MAP3K2 | 1.26719207 |
| 42 | CAMK2B | 1.26190504 |
| 43 | BUB1 | 1.25320846 |
| 44 | CSNK1G3 | 1.22253676 |
| 45 | MAPKAPK5 | 1.19818227 |
| 46 | NUAK1 | 1.18309825 |
| 47 | PNCK | 1.17007541 |
| 48 | MAP2K7 | 1.16650001 |
| 49 | BMPR1B | 1.16189108 |
| 50 | VRK1 | 1.13016355 |
| 51 | GRK1 | 1.10918433 |
| 52 | IRAK2 | 1.10034137 |
| 53 | MAPK15 | 1.09561815 |
| 54 | MUSK | 1.08781248 |
| 55 | PHKG2 | 1.04689995 |
| 56 | PHKG1 | 1.04689995 |
| 57 | CAMK2D | 1.04615266 |
| 58 | CAMK2G | 1.03320083 |
| 59 | PTK2 | 1.02784639 |
| 60 | NTRK1 | 1.01122835 |
| 61 | BRSK1 | 1.00083931 |
| 62 | IRAK1 | 0.99568754 |
| 63 | PINK1 | 0.95941647 |
| 64 | PLK2 | 0.95763257 |
| 65 | SCYL2 | 0.95067853 |
| 66 | UHMK1 | 0.94393888 |
| 67 | NEK6 | 0.93668658 |
| 68 | TESK1 | 0.93123744 |
| 69 | MET | 0.92935432 |
| 70 | PRKCE | 0.91645029 |
| 71 | PDK2 | 0.91143012 |
| 72 | ERBB3 | 0.89025976 |
| 73 | IRAK3 | 0.88263105 |
| 74 | NTRK3 | 0.87199664 |
| 75 | FRK | 0.85412443 |
| 76 | CAMK2A | 0.84103195 |
| 77 | CSNK1G1 | 0.81829942 |
| 78 | CSNK1G2 | 0.81596758 |
| 79 | LRRK2 | 0.79837371 |
| 80 | TESK2 | 0.78393418 |
| 81 | FGR | 0.77947533 |
| 82 | EPHA2 | 0.77097983 |
| 83 | TNK2 | 0.76968328 |
| 84 | IRAK4 | 0.76772687 |
| 85 | MAPK13 | 0.74756622 |
| 86 | PKN1 | 0.74631210 |
| 87 | SIK3 | 0.71025646 |
| 88 | ABL2 | 0.70245733 |
| 89 | PAK4 | 0.68367219 |
| 90 | AURKA | 0.67208739 |
| 91 | MINK1 | 0.66802314 |
| 92 | PRKCG | 0.65542288 |
| 93 | CSNK1A1L | 0.63947962 |
| 94 | EPHB1 | 0.63601321 |
| 95 | CDK14 | 0.63240288 |
| 96 | MAP3K3 | 0.62954934 |
| 97 | MAP2K2 | 0.62761147 |
| 98 | AKT3 | 0.62273860 |
| 99 | PIK3CA | 0.61920540 |
| 100 | FER | 0.61687007 |
| 101 | SRPK1 | 0.61256510 |
| 102 | RPS6KA5 | 0.60792778 |
| 103 | GRK6 | 0.59824060 |
| 104 | ERBB2 | 0.54890178 |
| 105 | DAPK3 | 0.54505772 |
| 106 | CSNK1A1 | 0.54011134 |
| 107 | PRKCI | 0.52850219 |
| 108 | EPHA4 | 0.51490718 |
| 109 | MAP3K11 | 0.51260781 |
| 110 | MAP3K13 | 0.50867445 |
| 111 | BLK | 0.50162552 |
| 112 | CDK5 | 0.50075643 |
| 113 | MAP2K6 | 0.49735556 |
| 114 | KSR2 | 0.48936092 |
| 115 | ADRBK1 | 0.47865250 |
| 116 | SYK | 0.46892872 |
| 117 | NEK1 | 0.46148203 |
| 118 | CSNK2A1 | 0.46133109 |
| 119 | RIPK4 | 0.45769923 |
| 120 | PAK1 | 0.45545208 |
| 121 | ROCK2 | 0.44706689 |
| 122 | CDK18 | 0.43819029 |
| 123 | CAMKK2 | 0.43747978 |
| 124 | IKBKB | 0.43609195 |
| 125 | DYRK1A | 0.43359335 |
| 126 | DAPK1 | 0.42319933 |
| 127 | SGK494 | 0.42271213 |
| 128 | SGK223 | 0.42271213 |
| 129 | PRKACA | 0.42180409 |
| 130 | INSRR | 0.41856872 |
| 131 | MAP2K1 | 0.41093822 |
| 132 | TAOK1 | 0.41049742 |
| 133 | TBK1 | 0.40974728 |
| 134 | PRKG2 | 0.40865216 |
| 135 | PAK3 | 0.40842378 |
| 136 | MAP3K9 | 0.40380187 |
| 137 | CSNK2A2 | 0.39387006 |
| 138 | PRKCQ | 0.39355019 |
| 139 | STK38L | 0.39102523 |
| 140 | CDK7 | 0.39097124 |
| 141 | CDK15 | 0.38174151 |
| 142 | RAF1 | 0.38075879 |
| 143 | CDK11A | 0.37142142 |
| 144 | RPS6KA4 | 0.35843368 |
| 145 | PLK1 | 0.31136733 |
| 146 | CCNB1 | 0.29927523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.28682394 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.27574366 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.78420452 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.67255653 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 3.26415446 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.87552695 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.79418091 |
| 8 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.68126534 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.67511137 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.59028410 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.37688042 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.25209451 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.22053729 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.15282048 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.94299942 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.86338421 |
| 17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.74873544 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.55096824 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.53359046 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.48843729 |
| 21 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.46507442 |
| 22 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.41483721 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.39226306 |
| 24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.38423563 |
| 25 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.36371865 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32273165 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.27804397 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27754198 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26539229 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17716180 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14693254 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.13519727 |
| 33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.11658668 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.10776235 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.07616959 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.02890072 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.01814390 |
| 38 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97284045 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96297252 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.95590452 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.94075676 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.93066737 |
| 43 | Metabolic pathways_Homo sapiens_hsa01100 | 0.92662598 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92415032 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90694189 |
| 46 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.89853080 |
| 47 | DNA replication_Homo sapiens_hsa03030 | 0.87469820 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87097869 |
| 49 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87018925 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.86337745 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85340061 |
| 52 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80854500 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79898423 |
| 54 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79839774 |
| 55 | Mismatch repair_Homo sapiens_hsa03430 | 0.79537785 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79359429 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78982375 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.78422801 |
| 59 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.77745136 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77679689 |
| 61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77131771 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76023914 |
| 63 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74181322 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73067600 |
| 65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72042075 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71220855 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.71178476 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67648179 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.64144357 |
| 70 | Taste transduction_Homo sapiens_hsa04742 | 0.63694480 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63049989 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.62802008 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61742751 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61691018 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61275927 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61125627 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.60892943 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.59884802 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.59654157 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.58292639 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.55633318 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55288652 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54552687 |
| 84 | Nicotine addiction_Homo sapiens_hsa05033 | 0.53678915 |
| 85 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52559030 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49743185 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49264259 |
| 88 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.48680664 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48344616 |
| 90 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.47661110 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47659403 |
| 92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47008730 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.46228007 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.45265751 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44934534 |
| 96 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.44299618 |
| 97 | Allograft rejection_Homo sapiens_hsa05330 | 0.44266561 |
| 98 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43567123 |
| 99 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43214921 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42541386 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42292835 |
| 102 | RNA transport_Homo sapiens_hsa03013 | 0.42049567 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.41071840 |
| 104 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39918558 |
| 105 | Cocaine addiction_Homo sapiens_hsa05030 | 0.38635487 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38319502 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.36705928 |
| 108 | Spliceosome_Homo sapiens_hsa03040 | 0.36118293 |
| 109 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34474541 |
| 110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.34415152 |
| 111 | Basal transcription factors_Homo sapiens_hsa03022 | 0.33163135 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31562076 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30995624 |
| 114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30899345 |
| 115 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.30503149 |
| 116 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30268897 |
| 117 | Retinol metabolism_Homo sapiens_hsa00830 | 0.28592422 |
| 118 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.27787290 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27484158 |
| 120 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.27350219 |
| 121 | Insulin secretion_Homo sapiens_hsa04911 | 0.27170209 |
| 122 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.25331873 |
| 123 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24826131 |
| 124 | Asthma_Homo sapiens_hsa05310 | 0.23389331 |
| 125 | Morphine addiction_Homo sapiens_hsa05032 | 0.22758131 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22411725 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.20076699 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.19985344 |
| 129 | Carbon metabolism_Homo sapiens_hsa01200 | 0.19867455 |
| 130 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18569634 |

